424 related articles for article (PubMed ID: 28474166)
1. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
Bögl HP; Aspenberg P; Schilcher J
Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
3. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
Ha YC; Cho MR; Park KH; Kim SY; Koo KH
Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
[TBL] [Abstract][Full Text] [Related]
4. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
[TBL] [Abstract][Full Text] [Related]
5. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
Grady MK; Watson JT; Cannada LK
Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
[TBL] [Abstract][Full Text] [Related]
7. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
[TBL] [Abstract][Full Text] [Related]
8. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
Spinelli MS; Marini E; Daolio PA; Piccioli A
Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
[TBL] [Abstract][Full Text] [Related]
9. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management.
Koh A; Guerado E; Giannoudis PV
Bone Joint J; 2017 Mar; 99-B(3):295-302. PubMed ID: 28249967
[TBL] [Abstract][Full Text] [Related]
10. Medication management after intramedullary nailing of atypical fractures.
Feron JM; Cambon-Binder A
Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
[TBL] [Abstract][Full Text] [Related]
11. High revision rate but good healing capacity of atypical femoral fractures. A comparison with common shaft fractures.
Schilcher J
Injury; 2015 Dec; 46(12):2468-73. PubMed ID: 26477344
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcome of intramedullary nailing in patients with complete atypical femoral fracture: A multicenter retrospective study.
Lee KJ; Yoo JJ; Oh KJ; Yoo JH; Rhyu KH; Nam KW; Suh DH
Injury; 2017 Apr; 48(4):941-945. PubMed ID: 28274470
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
Puah KL; Tan MH
Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
[No Abstract] [Full Text] [Related]
14. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.
Favinger JL; Hippe D; Ha AS
Skeletal Radiol; 2016 May; 45(5):627-33. PubMed ID: 26880003
[TBL] [Abstract][Full Text] [Related]
15. Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.
Kang JS; Won YY; Kim JO; Min BW; Lee KH; Park KK; Song JH; Kim YT; Kim GH
Int Orthop; 2014 Jun; 38(6):1247-53. PubMed ID: 24464018
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
Adams AL; Xue F; Chantra JQ; Dell RM; Ott SM; Silverman S; Giaconi JC; Critchlow C
Osteoporos Int; 2017 Jan; 28(1):413-417. PubMed ID: 27766369
[TBL] [Abstract][Full Text] [Related]
17. Burden of bisphosphonate-associated femoral fractures.
Shkolnikova J; Flynn J; Choong P
ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
[TBL] [Abstract][Full Text] [Related]
18. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
Reddy SV; Gupta SK
Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
[TBL] [Abstract][Full Text] [Related]
19. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
[TBL] [Abstract][Full Text] [Related]
20. Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
Aspenberg P; Schilcher J; Fahlgren A
Acta Orthop; 2010 Aug; 81(4):460-2. PubMed ID: 20515438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
